You are on page 1of 16

Certified Pharmaceutical

Good Manufacturing
Practices Professional

Quality excellence to enhance your career


and boost your organization’s bottom line

asq.org/certification
Certification from ASQ
is considered a mark of
quality excellence in many
industries. It helps you advance your
career, and boosts your organization’s
bottom line through your mastery of
quality skills. Becoming certified as
a Pharmaceutical GMP Professional
confirms your commitment to quality and
the positive impact it will have on your
organization.

2 Certified Pharmaceutical GMP Professional


Information
Certified Pharmaceutical Good
Manufacturing Practices Professional
The Certified Pharmaceutical Good Manufacturing Practices Professional
understands the GMP principles as regulated and guided by national
and international agencies for the pharmaceutical industry. This covers
finished human and veterinary drugs and biologics, ectoparasitacides, and
dietary supplements (alternatively called nutraceuticals where regulated
as drug products), as well as their component raw materials (includes
active pharmaceutical ingredients (APIs) and excipients) and packaging
and labeling operations.

Examination quality system, evaluate various


Each certification candidate is required types of audits and self-inspections,
to pass a written examination that and analyze documents and record
consists of multiple choice questions that management systems.
measure comprehension of the Body of • Will be able to distinguish between
Knowledge. The Pharmaceutical GMP and verify suitability of factors
Professional examination is a one-part, relating to laboratory systems,
150 question, four-hour exam and is including relevant compendia for the
offered in English. United States, Europe, and Japan,
investigations of aberrant laboratory
Education and/or Experience results, and instrument control and
You must have five years of on-the-job record-keeping.
experience in one or more of the areas
of the Certified Pharmaceutical GMP • Will be able to determine
Professional Body of Knowledge. A requirements and specifications for
minimum of three years of this experience construction of facilities, utilities and
must be in a decision-making position. equipment, evaluate automated or
“Decision-making” is defined as the computerized systems, and apply
authority to define, execute, or control business continuity plans and disaster
projects/ processes and to be responsible recovery techniques.
for the outcome. This may or may not • Will be able to use sampling plans and
include management or supervisory apply procedures for shipping and
positions. There are no education waivers receiving materials, analyze in-house
for this exam. storage, identification, and rotation of
For comprehensive exam information materials, and meet requirements for
on the Pharmaceutical GMP Professional materials traceability and sourcing,
certification, visit asq.org/certification. including returned goods.
• Will have a thorough understanding of
Minimum Expectations for a sterile and nonsterile manufacturing
Certified Pharmaceutical GMP systems and be able to analyze master
Professional and completed batch records, material
control procedures, and contamination
• Will have a fundamental controls.
understanding of regulatory agency
governance, including global • Will have a thorough understanding
regulatory framework, relevant of product design factors and phase-
regulations and guidelines, and appropriate GMP requirements. Will
mutual recognition agreements. be able to develop and evaluate
filling and packaging operations and
• Will be able to develop and apply controls, and analyze technology
elements and requirements of a transfer activities.

Certified Pharmaceutical GMP Professional 3


Body of Knowledge
Certified Pharmaceutical GMP
Professional (CPGP)
Topics in this body of knowledge (BOK) cover compliance with good
manufacturing practices (GMPs), as regulated and guided by national and
international agencies for the pharmaceutical industry. It covers finished
human and veterinary drugs and biologics,
ectoparasitacides, and dietary supplements
(alternatively called nutraceuticals where regulated
as drug products), as well as their component
raw materials (including active pharmaceutical
ingredients (APIs) and excipients) and packaging
and labeling operations.
This BOK includes subtext explanations and
corresponding cognitive levels for each topic
or subtopic. These details will be used by
the Examination Development Committee as
guidelines for writing test questions and are
designed to help candidates prepare for the exam
by identifying specific content that can be tested. The subtext is not intended
to limit the subject matter or be all-inclusive of what might be covered in an
exam, but is intended to clarify how topics relate to the role of the Certified
Pharmaceutical GMP Professional (CPGP). The descriptor in parentheses at
the end of each subtext entry refers to the highest cognitive level at which the
topic will be tested. A more comprehensive description of cognitive levels is
provided at the end of this document.

Therapeutic Goods Administration


I Regulatory Agency (TGA), USDA 9CFR, USDA Veterinary
Governance (15 Questions) Service Memoranda, and the
A. Global regulatory framework International Pharmaceutical
Identify the acts, statutes, directives, Excipients Council (IPEC).
etc., that apply to pharmaceuticals. (Understand)
(Understand) C. Mutual recognition agreements
B. Regulations and guidances Interpret requirements that govern
Interpret frequently used regulations product registration, import or export
and guidelines/guidances, including of raw material or finished product,
those published or administered the sharing of inspection findings, etc.
by the Pharmaceutical Inspection (Understand)
Convention and Pharmaceutical D. Regulatory inspections
Inspection Cooperation Scheme Define and describe various types
(PIC/S), Health Canada, the World of inspections (pre-approval (PAI),
Health Organization (WHO), the system-based, for-cause, license
International Conference on renewal, etc.), including what triggers
Harmonization (ICH), the European them, their frequency, and the
Medicines Agency (EMEA), the Food inspection process used. (Understand)
& Drug Administration (FDA), the

4 Certified Pharmaceutical GMP Professional


E. Enforcement actions D. Training and personnel qualification
Define and describe various 1.
Needs analysis
enforcement actions and Identify the requirements for
consequences (e.g., FDA 483s, determining the type of training
warning letters, license withdrawals, needed by quality staff members,
product seizure). (Understand) operations personnel, and related
F. Regulatory agency reporting functions. (Understand)
1.
Post-marketing changes 2.
Staff development requirements
Describe how post-marketing Determine proof of proficiency
changes to specifications, based on regulations, guidances,
processes, methods, etc., are and directives, including
assessed for impact to determine documented evidence (job titles,
the appropriate reporting method. job descriptions, etc.). (Apply)
(Understand) E. Change control and management
2.
Regulatory reporting requirements 1.
Pre-change analysis
Describe reporting requirements, Assess the impact that proposed
including supplements, NDA Field changes will have on products,
Alerts, Biological Product Deviation processes, facilities, utilities, etc.,
Reports, annual reports, variations to ensure risk minimization and
to dossiers and applications, etc. ongoing regulatory compliance.
(Understand) (Analyze)
G. Site master file (SMF) and drug 2.
Post-change analysis
master file (DMF) Analyze data and other inputs to
Describe the purpose and content of determine the results of a change,
these files. (Understand) and evaluate any new risk factors
created by the change. (Analyze)
II Quality Systems (30 Questions) F. Investigations and corrective and
preventive action (CAPA)
A. Quality management system (QMS)
1.
Trigger events
1.
QMS elements Identify trigger events that
Describe key elements of the necessitate investigation and
structure of a QMS, identify their the implications of the event
interrelationships, and develop elsewhere, and determine the
and describe their hierarchical underlying cause for the event.
positions. (Create) (Evaluate)
2.
QMS requirements 2.
Response actions
Apply requirements related to QMS Define immediate action, corrective
development and operations, as action, and preventive action, and
defined in ICH Q10, EU GMP, and explain their importance in terms
other guidances. (Apply) of management responsibility,
B. Quality unit (site) management methods of implementing them,
Describe quality management etc. (Evaluate)
elements for individual sites or units, 3.
CAPA feedback and trending
including responsibilities for company Describe how trending is used
management, qualified persons, batch in relation to CAPA data. Use
release requirements, the need for investigation feedback and CAPA
quality units to be independent from results to modify appropriate
operations, etc. (Understand) quality system elements. (Create)
C. Risk management G. Audits and self-inspections
Use various methods to apply risk
management principles, as described 1.
Audit processes and results
in ICH Q9 and other guidance or Differentiate between various audit
regulatory documents. (Apply) types (systems, product, process)
and analyze audit results to assess
conformance to requirements.
(Analyze)

Certified Pharmaceutical GMP Professional 5


2.
Audit follow-up K. Supplier and contractor quality
Use various methods to evaluate management
and verify the adequacy of 1.
Supplier quality systems
corrective actions taken. (Evaluate) Identify and interpret standards
3.
Ineffective corrective actions and regulations (e.g., ISO 17025)
Determine appropriate strategies to related to monitoring supplier and
use when corrective actions are not contractor quality management
implemented or are not effective. systems. (Analyze)
(Evaluate) 2.
Supplier controls
H. Documents and records management Assess the adequacy of controls
1.
GMP document system over procurement and receipt
Examine the GMP document of raw materials, components,
system, including corporate and contract services. Determine
standards, master plans, the need for formal contracts.
procedures, manufacturing and (Evaluate)
test instructions, etc., to determine 3.
Supplier evaluation
compliance to regulatory Assess the quality systems
requirements. (Analyze) of suppliers and contractors
2.
GMP compliance records using various methodologies,
Review various records (log including supplier qualification,
books, tags, training evidence, certification, evaluation, audit, as
etc.) to confirm compliance to well as supplied product or service
requirements. (Analyze) performance trending. (Evaluate)
3.
Record retention
Identify regulatory requirements III Laboratory Systems
for GMP compliance in record
(20 Questions)
retention. (Understand)
A. Compendia (United States, Europe,
I. Product quality complaints vs.
and Japan)
adverse event reports
1. Required vs. informational
1.
Quality complaints
compendia
Describe and distinguish between
Describe and distinguish between
product complaints and adverse
required and informational
events, and evaluate complaint-
(“general”) compendial chapters.
handling processes. (Evaluate)
(Apply)
2. Adverse events and
2. Marketing requirements vs.
pharmacovigilance
compendia
Describe adverse events
Distinguish among the U.S.
and identify the regulatory
Pharmacopoeia (USP), European
reports for these events and
Pharmacopoeia (PhEur or EP),
pharmacovigilance. (Understand)
and Japanese Pharmacopoeia
3.
Problem response (JP) in terms of requirements
Evaluate the level of action that for marketing authorization.
needs to be taken in response to (Understand)
these types of events, including
3.
Compendial methods review
corrections, product removal, etc.
Review compendial methods to
(Evaluate)
ensure that they are verified as
J. Product trend requirements suitable for use in the testing lab.
Describe and distinguish between (Evaluate)
components of the U.S. annual

product review (APR) and the
European product quality review
(PQR) with regard to data trends
and other required review methods.
(Understand)

6 Certified Pharmaceutical GMP Professional


4.
Compendial requirements review D. Specifications
Review test methods, 1.
Types of specifications
qualifications, and validations Determine whether approved
against required compendial specifications exist for raw
general chapters as well as against materials, intermediates, packaging
informational general compendial components, finished products, etc.
chapters whenever more specific (Analyze)
tests are not prescribed in the
product compendial monograph. 2.
Test data and specifications
(Analyze) Compare test data with
specifications to determine whether
5. Biological, microbiological, raw materials, intermediates,
chemical, and physical test packaging, or products meet
methods requirements. (Analyze)
Identify and interpret results from
compendia identification tests, 3.
Specifications revision
quantitative analysis, qualitative Review and update specifications
analysis, and other tests or studies when methods are revised or
for biological, microbiological, compendia are changed. (Evaluate)
and chemical, and physical tests. E. Laboratory record-keeping and data
(Apply) requirements
B. Laboratory investigations of aberrant 1. Record review
results Review laboratory records to
1.
Test data detect errors or falsification and to
Describe and distinguish among prevent loss of data. (Apply)
biological, microbiological, and 2.
Record-keeping requirements
chemical test data, and develop Identify and review record-keeping
procedures for investigating each requirements for data acquisition
type. (Analyze) systems. (Apply)
2.
Aberrant results 3.
Certificates of analysis (COAs)
Identify, analyze, and interpret Review COAs to ensure they are
data on processes or products complete, internally reviewed, and
that are out-of-specification (“no appropriately retained. (Apply)
test” in USDA) or out-of-trend, F. Laboratory handling controls
and determine the outcome of
the laboratory portion of the 1.
Sample identification
investigation and the criteria for Determine whether samples
further investigation. (Evaluate) are identified and handled in
accordance with requirements,
C. Instrument control and record- including name, sample
keeping identification, chains of custody,
1.
Instrument control etc. (Apply)
Examine operating procedures 2. Reagents, solutions, and standards
for instrument identification, identification
classification (e.g., GMP, for- Determine whether reagents,
information-only), and calibration, solutions, and standards
to meet requirements. (Apply) are identified and labeled in
2.
Instrument calibration accordance with requirements,
Determine whether instruments including opened-on, expiry,
are calibrated within the specified (validated) use-by, or recertify-by
range of operation, and whether dates. (Apply)
they are accurate and precise.
(Apply)
[Note: Calibration of facilities
equipment is covered in IV.E.]

Certified Pharmaceutical GMP Professional 7


3.
Storage requirements B. Utilities
Describe and use procedures to 1. Water supply systems
store samples, reagents, solutions,  Identify and interpret regulatory
and standards in appropriate requirements for design of
environmental conditions (e.g., water supply systems, including
temperature, humidity, light various unit operations (e.g.,
exposure, absence of oxygen, dechlorination, reverse osmosis,
etc.) to maintain the material’s deionization, distillation, etc.),
characteristics for testing. (Apply) delivery lines, back-flow or
G. Stability programs back-siphonage prevention, and
1. Release tests vs. stability- drainage systems, as appropriate
indicating tests for the type of water (potable,
Define and distinguish between purified, water for injection, etc.)
these two types of tests. (Apply) needed in various processing steps.
(Apply)
2.
Stability test data
Review stability data and identify 2.
Compressed air and gas systems
trends that can support or Identify and apply regulatory
challenge an expiry date. (Evaluate) requirements related to
compressed air and gas systems,
3.
Stability-point failure including storage, flow regulation,
Identify the stability-point failure of filtration, venting and purging, etc.
a product or material, and evaluate (Apply)
the implications for regulatory
compliance. (Evaluate) 3.
Utility design for production
Identify and select utility
H. Reserve samples and retains designs related to production
Describe the various regulatory steps (e.g., washing, sterilizing,
requirements for retains and reserve depyrogenation, etc.) for use with
samples. (Apply) specific materials and processes.
(Apply)
IV Infrastructure: Facilities, 4.
Utilities design specifications
Review operations of utilities to
Utilities, Equipment ensure that they meet design
(18 Questions) specifications. (Apply)
A. Facilities 5.
Utilities change control
1. Buildings Use various methods to verify that
 Determine requirements for change control practices are in use
appropriate size and construction to maintain the qualified state of
of buildings and areas as well as affected utilities. (Apply)
location of control systems. Ensure C. Equipment
that construction and location
facilitate proper operation and 1.
Equipment planning
minimize the risk of error and cross Review equipment location,
contamination. (Apply) design, construction, installation,
and maintenance based on the
2. Manufacture and storage operations to be conducted. (Apply)
environment
Identify requirements for 2.
Equipment layout
appropriate lighting, ventilation, Determine the layout of equipment
and drainage to avoid adversely to minimize the risk of errors,
affecting product (either directly or to facilitate effective cleaning
indirectly) during manufacture and and maintenance, and to avoid
storage. (Apply) contamination or any other
undesired effect on product quality.
3.
Facilities change control (Apply)
Use various methods to verify that
change control practices are in use
to maintain the qualified state of
the facilities. (Apply)

8 Certified Pharmaceutical GMP Professional


3. Equipment cleaning and 2.
Cleaning procedures
maintenance Review cleaning procedures in
Review procedures and schedules accordance with prior cleaning
for equipment cleaning, validation, whenever validation is
maintenance, and, where required and performed.
necessary, sanitization to ensure 3.
Sanitization procedures
that they meet requirements. Review sanitization procedures for
(Apply) facilities and equipment, including
4. Equipment cleaning validation or details on cleaning schedules,
verification methods, equipment, materials,
Evaluate the need and etc., and verify that sanitizers,
methodology for product-contact disinfectants, sporicides, and
cleaning validation, verification, or sterilants are used in accordance
both. (Evaluate) with marketing authorization and
5.
Equipment change control any required validation studies.
Use various methods to verify that (Apply)
change control has maintained 4.
Pest control
the qualified state of equipment. Review and verify that a pest
(Apply) control program is in place and
D. Qualification and validation that it uses authorized rodenticides,
Verify that the qualifications and insecticides, fungicides, fumigating
validations of facilities, equipment, agents, and appropriate traps for
and utilities are conducted pest elimination, etc. (Apply)
in accordance with various 5. Sterilization processes
requirements, including factory Verify that appropriate sterilization
and site acceptance testing (FAT/ processes are in place. (Apply)
SAT), installation, operational, and G. Automated or computerized systems
performance qualification (IQ/OQ/PQ)
prior to process validation. (Analyze) 1.
Validation procedures
Review procedures for validation of
E. Maintenance and metrology systems these systems, including building
1.
Maintenance procedures maintenance systems, utilities,
Verify that procedures are in and equipment. Verify that critical
use for routine and nonroutine parameters for their operation and
maintenance of heating, ventilating, maintenance are controlled and
and air conditioning (HVAC) monitored. (Evaluate)
systems; air and water filters; and 2. Open and closed computerized
other GMP equipment and utilities; systems
etc. (Analyze) Distinguish between open and
2.
Metrology change control closed computerized systems.
Verify that appropriate calibration (Apply)
and engineering/equipment change 3.
Configuration control
control procedures are in use, and Verify that version control and
that a metrology program exists configuration are maintained and
for the calibration of instruments monitored. (Evaluate)
that control manufacturing
facilities, utilities, and equipment. 4.
Security requirements
(Analyze) [Note: Calibration of Evaluate computerized systems to
instrumentation is covered in ensure they meet regulatory and
III.D.3.] guidance requirements for key
elements, such as access control,
F. Cleaning, sanitization, and data protection, change control,
sterilization systems data archiving, maintenance,
1.
Washing facilities transcription, audit trail, periodic
Verify that washing facilities are system monitoring, etc. (Evaluate)
adequate and properly located.
(Apply)

Certified Pharmaceutical GMP Professional 9


H. Business continuity and disaster C. Material storage, identification, and
recovery planning rotation
1.
Supply chain impact 1.
Storage suitability
Review plans and verify procedures Confirm that the storage
for disaster recovery and business environment is suitable, controlled,
continuity that will guard and monitored as required for the
operations from interruption to the type of materials. (Analyze)
supply chain. (Evaluate) 2.
Storage labels
2.
Contingency plan Confirm that the identification label
Verify the testing and effectiveness for stored materials contains the
of contingency plans as required or required information. (Analyze)
proceduralized. (Apply) 3.
Stock rotation
Define and use stock rotation
V Materials and Supply Chain requirements, such as first-in/first-
out (FIFO) and first-expired/first-out
Management (15 Questions) (FEFO). (Apply)
A. Receipt of materials 4.
Retest dates vs. expiration dates
1.
Incoming materials Describe the difference between
Describe and use processes retest dates and expiration dates.
to receive and store incoming (Understand)
materials, including raw materials, 5.
Mix-up risk
tank farm liquid chemicals or Describe potential sources of
solvents, components, labels, mix-up and identify methods
etc., and take appropriate action to minimize their risk, including
on deviations, such as damaged material segregation, labeling,
materials, materials from special storage for rejects, control
unapproved suppliers, missing of material returns, lot-control
documentation, etc. (Apply) methods, special process for
2.
Inventory transactions materials with similar names, etc.
Describe and use procedures (Analyze)
for documenting inventory D. Shipping and distribution
transactions, such as material
1. Temperature-sensitive
selection and “stop shipments” for
requirements
quality holds. (Apply)
Identify special requirements for
B. Sampling processes temperature-sensitive products,
1.
Sampling plans including tertiary packaging design,
Review sampling plans for monitoring devices, etc. (Analyze)
representative sampling, 2.
Special requirements
appropriate sample size, and test or Determine specific product
inspection criteria. (Apply) requirements and apply them to
2.
Sampling environment routine shipping processes. (Apply)
Differentiate and apply the 3.
Report requirements
requirements for sampling Analyze shipping reports and
environment and utensils to the transportation requirements in
type of the material being sampled. accordance with good distribution
(Apply) practices. (Analyze)
3.
Cleaning 4.
Supply chain security
Ensure that the sampling Identify and apply the various
environment is appropriately means to secure the supply chain,
cleaned and monitored and that including tamper-evident seals,
sampling utensils are appropriately shipping manifests, verification of
cleaned or are single-use. (Apply) documentation, barcoding, radio
frequency identification (RFID), etc.
(Apply)

10 Certified Pharmaceutical GMP Professional


E. Traceability and sourcing B. Production operations
1.
Traceability requirements 1.
Application factors
Define and differentiate the Describe and differentiate the
requirements for traceability of requirements for manufacturing
incoming materials, intermediates, processes according to their
and finished drugs. (Apply) application: human or veterinary
2.
Biological agent requirements drugs or biologics. (Apply)
Identify and apply the requirements 2.
Utility requirements
related to biological agents such Identify the facility and utility
as bovine and transmissible requirements that are appropriate
spongiform encephalopathy (BSE for different production
and TSE). (Apply) environments and product types,
3. Pedigree and sourcing including sterile vs. nonsterile
requirements manufacturing, solid and semisolid
Identify and apply requirements for dosage forms, liquids, creams,
maintaining pedigree and sourcing ointments, combination products,
details for active pharmaceutical etc. (Analyze)
ingredients (APIs), biological 3.
Sanitization and protection
starting materials, excipients, Identify various production
intermediates, finished products, operations that require gowning,
etc., and document the supply sanitization, hygiene, and other
chain, from raw materials through product-protective steps. (Apply)
wholesale or retail to end user. C. In-process controls
(Apply)
1.
In-process testing
F. Salvaged/returned goods and Identify appropriate tests for each
destruction step in the manufacturing process
1.
Disposition and review results. (Analyze)
Review salvaged and returned 2.
Critical process parameters (CPPs)
goods and evaluate them for Identify and select appropriate
disposition. (Evaluate) CPPs. (Analyze)
2.
Destruction facilities and processes 3.
Process capability studies
Determine whether qualified Review process capability studies,
facilities and processes need to be and calculate Cp and Cpk. (Apply)
used to destroy materials. (Apply)
4.
Specification limits
Assess specification limits
VI Sterile and Nonsterile in relation to registration or
compendial requirements.
Manufacturing Systems (Evaluate)
(25 Questions)
D. Dispensing and weighing controls
A. Master batch and completed batch
records 1.
Staging areas
Review product dispensing and
1.
Required elements after-dispensing staging areas
Review batch records for required to determine whether they meet
elements, including proper requirements. (Analyze)
issuance, sections on yields, critical
manufacturing step verification, 2.
Dispensing materials
processing instructions, hold times, Identify the requirements for
etc. (Apply) using weighing equipment and
handling utensils for dispensing
2.
Record processing requirements raw materials or intermediates,
Confirm that batch records meet including proper cleaning, labeling,
requirements for execution, review, and environmental controls,
and disposition decisions. (Analyze) based on the type of material and
manufacturing process being used.
(Apply)

Certified Pharmaceutical GMP Professional 11


E. Requirements for critical unit 2.
Risk mitigation
processes Describe and apply various
1.
Parameters for sterilization techniques for mitigating the risk
Identify required CPPs for such of these events, including cleaning,
unit processes as sterilization or facility and equipment design,
sterilizing filtration, aseptic filling, qualified disinfectants, operator
depyrogenation, lyophilization, training, validation, monitoring, etc.
other drying processes, tablet (Apply)
granulation and compression, G. Reprocessed and reworked materials
terminal sterilization, cream or 1.
Disposition process
ointment emulsification, etc. Distinguish reprocessing from
(Analyze) reworking and apply appropriate
2.
Validation studies documentation, approval, and
Explain and evaluate the disposition methods for these
validation studies, specifically materials. (Apply)
the methodologies and 2.
Storage
acceptance criteria—required Describe and apply requirements
before implementing critical unit for segregation and secure storage
processes. Explain and evaluate of these materials. (Apply)
validation studies required for
aseptic processes including
process simulations (“media fills”). VII Filling,
 Packaging, Labeling
(Evaluate)
(17 Questions)
3.
Unit processes
A. Filling operations and controls
Assess unit processes or their
validations for deviations requiring 1.
Materials control
investigation. (Analyze) Develop and review procedures
to ensure the identity, strength,
4.
Operating procedures
and purity of specified materials
Review qualification and validation
(e.g., liquids, powders, ointments,
results and confirm that they are
tablets, capsules, suspensions,
reflected in operating procedures.
powders, etc.) and to prevent them
(Analyze)
from being altered. (Create)
5.
Re-evaluation and revalidation
2.
Filling equipment control
Determine appropriate criteria
Analyze the controls needed
and frequency for re-evaluation
for various types of production
and revalidation of unit processes.
equipment and processes and
(Evaluate)
ensure that the appropriate
6. Environmental monitoring controls are in place to verify filling
requirements criteria. (Analyze)
Differentiate between
3.
Contamination controls
environmental monitoring
Identify controls to prevent
requirements for different
microbial and other contamination
manufacturing area classifications.
at all stages of filling. (Apply)
(Apply)
4.
Staged materials
7.
Monitoring tools
Review staged materials and
Describe and use various
confirm that they are approved for
monitoring tools to measure
use. (Apply)
viable and nonviable particulates,
pressure differentials, temperature, 5.
Status labeling
humidity, etc. (Apply) Identify and apply proper status
labeling throughout the process.
F. Contamination and cross-
(Apply)
contamination
1.
Sources
Identify potential sources for these
events. (Apply)

12 Certified Pharmaceutical GMP Professional


B. Environmental monitoring E. Packaging operations and controls
Use various monitoring techniques 1.
Content protection
(active air sampling, settle plates, Develop and apply procedures to
nonviable particle counting, contact prevent the environment or events
plates for surfaces and people, from altering the identity, strength,
etc.) to determine that appropriate and purity of the package content.
environmental conditions are (Create)
maintained in various operations.
(Apply) 2. Qualification and maintenance of
equipment
C. In-process and finished goods Ensure that equipment used in
inspections packaging operations is qualified
1. Finished goods inspections and maintained. (Apply)
 Develop criteria for in-process and 3.
Line clearance operations
finished goods inspections of filled Determine that line clearance
and packaged materials, including is performed and documented.
seal tests, torque testing, bottle (Apply)
rejection systems, etc. (Create)
4.
Quality check criteria
2.
Vision and detection systems Identify and apply specified criteria
Ensure that vision and detection when quality checks are performed.
systems are qualified, calibrated, (Apply)
and challenged as required for the
system. (Apply) 5.
Cut-label procedures
Apply appropriate procedures for
3.
Defect characterizations cut labels, splices, etc. (Apply)
Ensure that defect characterizations
are identified for each product and 6.
Hand-applied label procedures
can be detected by inspection or Ensure that hand-applied labels are
test. (Apply) 100% inspected. (Apply)
4.
Equipment failure detection 7.
Production process controls
Confirm by inspection or test that Distinguish between controls
equipment failures can be detected. needed for different types of
(Apply) production processes. (Analyze)
D. Parenteral product inspection 8.
Contamination controls
Identify controls to prevent
1.
Staff evaluation microbial and other contamination
Ensure that staff who perform at all stages of packaging. (Apply)
manual inspections are properly
trained and that their inspections 9.
Tamper-evident packaging
meet reproducibility requirements. Ensure that tamper-evident and
(Apply) child-proof packaging requirements
are in place for required products.
2.
Automated inspection processes (Apply)
Ensure that automated inspection
processes are validated. (Apply) F. Labeling operations and controls
3.
Defect library 1.
Label printing in packaging
Ensure that a defect library is Confirm and document that any
available to confirm proper printing done separately or in the
manual and automated inspection course of packaging is performed
processes. (Apply) correctly. (Apply)
4.
Inspector requirements 2.
Quality of print used
Establish requirements for Ensure that any type of print
inspectors to have periodic eye information (engraved, embossed,
examinations. Confirm and etc.) on packaging materials is clear
document that they take frequent and resistant to fading, smudging,
breaks from inspection. (Apply) or erasure. (Apply)
3.
Label reconciliation
Confirm that label reconciliation is
performed. (Apply)

Certified Pharmaceutical GMP Professional 13


4.
Label changes B. Phase-appropriate GMP requirements
Determine whether regulatory 1.
ICH Q8
notification and approval is Identify recommendations
required for proposed label contained in the ICH Q8 guidance
changes. (Apply) for pharmaceutical development.
5.
Unused labels (Understand)
Confirm that procedures are in 2.
Development phases
place and in use for destroying Identify recommendations and
unused labels and labeling requirements in relation to
materials. (Apply) phases of development, including
G. Filling and packaging records method qualification/validation,
1.
Terms comparability protocols, adoption
Define terms related to these of critical process parameters and
records, including evidence of specifications, etc. (Understand)
line clearance, printed material 3.
Combination products
reconciliation, yields, etc. Identify various studies required for
(Understand) combination drug-device or drug-
2.
Setup instructions delivery products. (Understand)
Ensure that packaging line setup 4.
Clinical trials material
instructions are appropriate for all Describe and apply requirements
components. (Apply) for packaging of clinical trials
H. Artwork development and controls material/IMPs. (Apply)
1.
Terms C. Raw materials, packaging,
Define terms related to artwork/ and infrastructure for product
graphics, offline printing, roll label development
splicing, gang printing, secure Select appropriate development
storage and destruction, etc. studies for raw material selection and
(Understand) evaluate the results to determine their
critical quality attributes. (Analyze)
2.
Access control
Ensure that controls are in place D. New product development studies
for the creation and use of artwork. and reports
(Apply) Analyze studies and reports,
including stability reports, material
VIII Product
 Development and compatibility, method development,
Technology Transfer development reports, etc., to
(10 Questions) support product development and
submissions. (Analyze)
A. Quality by design concepts
E. Scale-up and transfer activities
1. Critical quality attributes (CQAs)
and critical process parameters 1. Development and validation
(CPPs) reports
Identify CQAs for products and Identify and distinguish
CPPs for processes. (Understand) development and validation
studies. (Understand)
2.
Design space
Define the concept of design space 2.
Technology transfer types
as it is used throughout the product Define different types of technology
life cycle. (Understand) transfer, including, manufacturing
site change, analytical laboratory
3. Process analytical technology site change, etc., and analyze
(PAT) tools inter-site comparison of results.
Identify PAT tools, including (Analyze)
multivariate data analysis, process
analyzers, process and endpoint 3. Transfer efficiency
controls, etc., and describe their  Define various studies, including
use in supporting the manufacture ranging, capability, in-process
of quality products. (Remember) control, hold times, shipping, etc.,
to improve transfer efficiency
between development and
commercial processes. (Apply)

14 Certified Pharmaceutical GMP Professional


Levels of Cognition
Based on Bloom’s Taxonomy—Revised (2001)
In addition to content specifics, the subtext for each topic in this BOK also indicates the
intended complexity level of the test questions for that topic. These levels are based
on “Levels of Cognition” (from Bloom’s Taxonomy—Revised, 2001) and are presented
below in rank order, from least complex to most complex.

Remember Evaluate
(Also commonly referred to as recognition, Be able to make judgments regarding
recall, or rote knowledge.) Be able to the value of proposed ideas, solutions,
remember or recognize terminology, methodologies, etc., by using appropriate
definitions, facts, ideas, materials, patterns, criteria or standards to estimate accuracy,
sequences, methodologies, principles, etc. effectiveness, economic benefits, etc.
Understand Create
Be able to read and understand descriptions, Be able to put parts or elements together in
communications, reports, tables, diagrams, such a way as to show a pattern or structure
directions, regulations, etc. not clearly there before; be able to identify
Apply which data or information from a complex
Be able to apply ideas, procedures, set is appropriate to examine further or from
methods, formulas, principles, theories, etc., which supported conclusions can be drawn.
in job-related situations.
Analyze
Break down information into its constituent
Be able to break down information into its
constituent parts and recognize the parts’
relationship to one another and how they are
organized; identify sublevel factors or salient
data from a complex scenario.

Visit asq.org/certification for comprehensive


exam information.

15 Certified Pharmaceutical GMP Professional Certified Pharmaceutical GMP Professional 15


Enhance your career with ASQ certification today! Visit www.asq.
org/certification for complete certification information including:

Applications
Enhance your career
Available certifications and language options

with ASQ
Reference materials certification
today!
Study guides and test-taking tips
Comprehensive exam information
ASQ Sections
Visitcontacts
International asq.org/certification
for additional
Endorsements certification
information, including:
• Applications
•A
 vailable certifications and
international language options
• Reference materials
• Study guides and test-taking tips
•C
 omprehensive exam
information
• ASQ sections
• International contacts
• Endorsements

Item B1638

You might also like